U.S. flag

An official website of the United States government

NM_000169.3(GLA):c.1087C>T (p.Arg363Cys) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 3, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000179729.1

Allele description

NM_000169.3(GLA):c.1087C>T (p.Arg363Cys)

Genes:
RPL36A-HNRNPH2:RPL36A-HNRNPH2 readthrough [Gene - HGNC]
GLA:galactosidase alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_000169.3(GLA):c.1087C>T (p.Arg363Cys)
HGVS:
  • NC_000023.11:g.101398012G>A
  • NG_007119.1:g.14952C>T
  • NM_000169.2:c.1087C>T
  • NM_000169.3:c.1087C>TMANE SELECT
  • NM_001199973.2:c.300+2555G>A
  • NM_001199974.2:c.177+6190G>A
  • NP_000160.1:p.Arg363Cys
  • NP_000160.1:p.Arg363Cys
  • LRG_672t1:c.1087C>T
  • LRG_672:g.14952C>T
  • LRG_672p1:p.Arg363Cys
  • NC_000023.10:g.100653000G>A
  • NM_000169.2(GLA):c.1087C>T
  • NR_164783.1:n.1166C>T
  • p.Arg363Cys
Protein change:
R363C
Links:
dbSNP: rs797044776
NCBI 1000 Genomes Browser:
rs797044776
Molecular consequence:
  • NM_001199973.2:c.300+2555G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001199974.2:c.177+6190G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000169.2:c.1087C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_000169.3:c.1087C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_164783.1:n.1166C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
5

Condition(s)

Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000232023EGL Genetic Diagnostics, Eurofins Clinical Diagnostics
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Feb 3, 2015)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown5not providednot providednot providednot providedclinical testing

Citations

PubMed

Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype.

Shabbeer J, Yasuda M, Luca E, Desnick RJ.

Mol Genet Metab. 2002 May;76(1):23-30.

PubMed [citation]
PMID:
12175777

A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry disease.

Wu X, Katz E, Della Valle MC, Mascioli K, Flanagan JJ, Castelli JP, Schiffmann R, Boudes P, Lockhart DJ, Valenzano KJ, Benjamin ER.

Hum Mutat. 2011 Aug;32(8):965-77. doi: 10.1002/humu.21530. Epub 2011 Jul 12.

PubMed [citation]
PMID:
21598360
PMCID:
PMC3170878

Details of each submission

From EGL Genetic Diagnostics, Eurofins Clinical Diagnostics, SCV000232023.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided5not providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided5not providednot providednot provided

Last Updated: Nov 20, 2021